Sono-Tek stock falls 14% on second quarter earnings, revenue miss
Sono-Tek (SOTK) reported Q2 fiscal 2027 earnings and revenue below estimates, with shares down 14.47% premarket. Revenue was $5.23M, up 1% YoY, while EPS was $0.02, missing estimates by $0.02. Medical sector sales surged 209% to $3.11M. The company maintained full-year guidance for flat to modest growth, citing order timing. Backlog increased 23% to $9.51M.
How this was made
The 30-second read
Why it matters
The earnings miss triggered a sharp pre‑market decline, highlighting execution risk in large‑order timing.
Market read
Micro‑cap earnings miss with immediate price reaction; relevant for short‑term traders.
What to watch
Backlog increase and post‑quarter orders suggest near‑term revenue upside.
Background
Sono‑Tek provides precision ultrasonic coating systems for medical and industrial markets.
Ticker impact
Sono‑Tek reported Q2 FY2027 earnings and revenue miss, causing a 14.5% pre‑market drop.
downward pressure as the market prices in the earnings shortfall
Adjusted EPS of $0.02 missed consensus $0.04 and revenue fell short, prompting immediate sell‑off.
Market effects
Ultrasonic coating equipment sector may see short‑term weakness as a peer misses estimates.
US micro‑cap market may experience modest sell pressure.
Limited; impact confined to niche manufacturing segment.
Counterpoint
If the medical‑segment growth sustains, the stock could rebound despite the miss.
Key entities
- ExecutiveSteve Harshbarger
President and CEO of Sono‑Tek, quoted on fiscal outlook.
